$71.50
▲ +0.4% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
TMDX: Raising target price to $71.00
Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?
Overview
52-week range
$60
$156
12% of range
Avg surprise (last 3)
+60.5%
Avg reaction (last 2)
-2.5%
0% positive
Latest IV / EM
86%
EM ±19.8% · $75 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $0.30 | $0.62 | -51.6% | -57.1% | -2.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.66 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $0.92 | $0.48 | +91.7% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.70 | $0.29 | +141.4% | — | -2.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.12 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.35 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.35 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.78 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.03 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Jul 29, 2026 | Jun/2026 | OTHER | $0.50 | $0.92 | -45.6% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $174M | — | $144M | $157M | $144M | — | $109M | $114M |
| Cost of revenue | $73M | — | $59M | $61M | $55M | — | $48M | $45M |
| Gross profit | $101M | — | $85M | $97M | $88M | — | $61M | $69M |
| Operating income | $13M | — | $23M | $37M | $27M | — | $4M | $13M |
| Net income | $7M | — | $24M | $35M | $26M | — | $4M | $12M |
| EPS (diluted) | $0.20 | — | $0.66 | $0.92 | $0.70 | — | $0.12 | $0.35 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | $330M | $363M |
| Inventory | $50M | $49M | $45M | $39M | $43M | $47M | $52M | $49M |
| Total current assets | $619M | $638M | $613M | $558M | $506M | $497M | $492M | $509M |
| Total assets | $1.43B | $1.07B | $946M | $891M | $838M | $804M | $786M | $759M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $941M | $595M | $591M | $572M | $571M | $575M | $576M | $569M |
| Total equity | $494M | $473M | $355M | $318M | $266M | $229M | $210M | $190M |